Correlations between Bone Histopathology and Serum Biochemistry in Uremic Patients on Chronic Hemodialysis

Abstract

To define which noninvasive investigations are of value in predicting bone histology, we analyzed transiliac bone specimens (66 biopsies, 14 autopsies) from 80 uremic patients on chronic dialysis. Results were compared with values of different measurements of parathyroid hormone (PTH), alkaline phosphatase (APH), osteocalcin, calcitonin, baseline and post-deferroxamine (DFO) aluminium (Al), - β₂ microglobulin, ferritin and bone mineral density Among histomorphometric parameters, woven osteoid, active osteoblastic surface and resorption surface showed the best correlations with dynamic and biochemical marks of active bone metabolism. Among biochemical parameters, intact PTH and APH were better related to histomorphometric and dynamic bone parameters than other PTH measurements as well as osteocalcin, while calcitonin was related to no parameters. Stainable Al alone, and not total bone Al content was related to bone histology. Baseline Al was related to lamellar osteoid, while post-DFO Al was related to stainable Al. β₂ microglobulin was positively related to active osteoid surface and ferritin was inversely related to the mineral apposition rate, while bone mineral density was related only to total bone volume.

We conclude that, though definite diagnosis requires the use of histological methods, few simple biochemical parameters may offer insight to the bone metabolic status, useful to the physician in day to day clinical practice.

Keywords

Bone histopathology Osteodystrophy Parathyroid hormone Aluminium Bone mineral density β2 microglobulin

Get full access to this article

View all access options for this article.

References

Heaf

J.G.

, Joffe

, Andersen

Jr.

. Noninvasive diagnosis of uremic osteodystrophy: uses and limitations. Am J Nephrol 1987; 7: 200–11.

Hutchinson

A.J.

, Withehouse

R.W.

, Boulton

H.F.

Correlation of bone histology and parathyroid hormonic, vitamin D3 and radiology in end-stage renal disease. Kidney Int 1993; 44: 1071–2.

Quanle

, Monier-Faugere

M-C

, Geng

, Malluche

H.H.

. Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. Am J Kidney Dis 1995; 26: 622–37.

Chazan

J.A.

, Libbey

N.P.

, London

M.R.

, Pono

, Aruelo

J.G.

. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings. Clin Nephrol 1991; 2: 78–85.

Pei

, Hercz

, Greenwood

Non-invasive prediction of aluminium bone disease in hemo- and peritoneal dialysis patients. Kidney Int 1992; 41: 1374–82.

Mazzaferro

, Coen

, Ballanti

Deferoxamine test and PTH serum levels are useful not to recognize but to exclude aluminum-related bone disease. Nephron 1992; 61: 151–7.

Fletcher

, Jones

K.G.

, Rayner

H.C.

Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology. Nephron 1997; 75: 412–9.

Garcia-Carrasca , Gruson

, De Vernejoul

, Denne

M.A.

, Miravet

. Osteocalcin and bone morphometric parameters in adult with bone disease. Calcif Tissue Int 1988; 42: 13–7.

Mazzaferro

, Coen

, Ballanti

. Osteocalcin, iPTH, alkaline phosphatase and X-rays scores as predictive indices of histomorphometric parameters in renal osteodystrophy. Nephron 1990; 56: 261–6.

10.

Jaeger

, Jones

, Clemens

T.L.

, Hayslett

J.P.

. Evidence that Calcitonin stimulates 1,25 Dihydroxyvitamin D production and intestinal absorption of calcium in vivo. J Clin Invest 1986; 78: 456–61.

11.

Canalis

, Mccarthy

, Centrella

. Growth factors factors and the regulation of bone remodeling. J Clin Invest 1988; 81: 277–81.

12.

Sprague

S.M.

, Popovitzer

M.M.

. Is β₂ microglobulin a mediator of bone disease? Kidney Int 1995; 1–6.

13.

Van DeVyver

F.L.

, Visser

M.J.

, D'Hase

P.C.

, De Broe

M.E.

. Iron overload and bone disease in chronic dialysis patients. Contrib Nephrol, Karger Basel, 1988; 64: 134–43.

14.

Phelps

K.R.

, Vigorita

V.J.

, Bansal

, Einhorn

T.A.

. Histochemical demonstration of iron but not Aluminum in a case of dialysis-associated osteomalacia. Am J Med 1988; 84: 775–80.

15.

Denton

, Freemont

A.J.

, Bell

AJ:

Detection and distribution of aluminium in bone. J Clin Pathol 1984; 136–42.

16.

Parfitt

A.M.

. The localization of aluminum in bone: implications for the mechanism of fixation and for the pathogenesis of aluminium-related bone disease. Int J Artif Organs 1988; 11: 79–90.

17.

Cournot-Witner

, Zingraff

, Plachot

J.J.

. Aluminium localization in bone form hemodialyzed patients: relationship to matrix mineralization. Kidney Int 1981; 20: 375–85.

18.

Vernejoul

M.C.

, Belenguer

, Halkidu

. Histomorphometric evidence of deleterious effect of Aluminum on osteoblasts. Bone 1985; 6: 15–20.

19.

Malluche

H.H.

, Smith

A.J.

, Abreo

, Faugere

M.C.

. The use of deferoxamine in the management of aluminum accumulation in bone in patients with renal failure. N Eng J Med 1984; 311: 140–4.

20.

McClure

, Fazzalari

N.L.

, Fassetti

R.G.

, Pugsley

P.G.

. Changes in bone histoquantitative parameters and histochemical staining reactions for aluminum in a group of patients with chronic renal failure following a reduction in the aliminum concentration of the hemodialysis fluid. J Clin Pathol 1984; 37: 743–7.

21.

Parfitt

A.M.

, Drezner

M.K.

, Glorieux

F.H.

, Kanis

J.A.

, Malluche

, Meunier

P.J.

, Ott

S.M.

, Recker

R.R.

. Bone histomorphometry: Standardization of Nomenclature, Symbols and Units. J Bone Mineral Res 1987; 2: 595–610.

22.

Koch

K.M.

. Dialysis related amyloidosis (Nephrology Forum) Kidney Int 1992; 41: 1416–29.

23.

Jadoul

, Garbar

, Noel

Histological prevalence of β₂ -microglobulin amyloidosis in hemodialysis: a prospective post-mortem study. Kidney Int 1997; 51: 1928–32.

24.

Malluche

H.H.

, Faugere

. Renal bone disease 1990: an unmet challenge for the nephrologist. Kidney Int 1990; 38: 193–211.

25.

Sherrard

D.J.

, Hercz

, Pei

The spectrum of bone disease in end-stage renal failure - an evolving disorder. Kidney Int 1993; 43: 436–42.

26.

Gonzales

E.A.

, Martin

Renal osteodystrophy: pathogenesis and management. Nephrol Dial Transplant 1995; 13–21.

27.

Ballanti

, Martin Wedard

, Bonucci

. Frequency of adynamic bone disease and aluminum storage in Italian uraemic patients - retrospective analysis of 1429 iliac crest biopsies. Nephrol Dial Transplant 1996; 11: 663–2.

28.

Langub

M.C.

, Koszewski

N.J.

, Turner

H.V.

, Monier-Faugere

M-C

, Geng

, Malluche

H.H.

. Bone resorption and mRNA expression of IL-6 receptor in patients with renal osteodystrophy. Kidney Int 1996; 50: 515–20.

29.

Salusky

I.B.

, Goodman

W.G.

. Growth hormone and calcitriol as modifiers of bone formation in renal osteodystrophy. Kidney Int 1995; 48: 657–65.

30.

Gonzales

E.A.

, Martin

K.J.

. Bone cell response in uremia. Semin Dialysis 1996; 9: 339–46.